Correction
This article was originally published in The Gray Sheet
Executive Summary
Gen-Probe: In the Jan. 18, 2010 issue (1p. 14), a "J.P. Morgan Healthcare Conference In Brief" item incorrectly notes that Gen-Probe plans to submit a 510(k) to FDA for its Aptima HPV assay to run on its Tigris system. The company plans to submit a PMA